Finding new markers for pancreatic IPMN progression
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks for new markers in the blood or tissues of people with a pancreatic condition called IPMN. The goal is to find better ways to predict if IPMN might turn into cancer and to help choose the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of pancreatic cyst called IPMN (intraductal papillary mucinous neoplasm) that is either being watched or has turned into cancer
- OR you have pancreatic cancer that started from an IPMN and haven't had treatment yet
- You are 18 years old or older
- You are willing to give written permission (informed consent) to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for markers in cyst fluid and tissue to help identify which IPMN growths are becoming invasive (spreading). It may help doctors decide who needs surgery.
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
This trial studies a blood test to find pancreatic cancer early. It may help people who are at risk or have suspicious signs.
This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.
This study looks for “biomarkers,” meaning measurable signs in the blood, in people diagnosed with intraductal papillary mucinous neoplasm (IPMN). It aims to better understand what changes happen in this condition and may help future diagnosis or monitoring.
This study looks for markers in tumor tissue that could help find pancreatic cancer earlier. You may be able to join if you are having surgery for a suspected pancreatic tumor and the final diagnosis is a precancerous condition or pancreatic cancer.
Hear when a new IPMN, Pancreatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.